DP-R212 Pharmacokinetic Study Phase I

NCT02814500 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DP-R212
DRUG: Amlodipine
DRUG: Rosuvastatin

Sponsor

Alvogen Korea